<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="2453">Acyclovir</z:chebi> is a potent <z:chebi fb="4" ids="36044">antiviral drug</z:chebi>, of proven efficacy in the treatment of <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex virus infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Since this virus has been implicated in the aetiology of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's syndrome, the effect of <z:chebi fb="4" ids="2453">acyclovir</z:chebi> on orogenital ulceration in this condition was determined in a randomized, double-blind, placebo-controlled, crossover trial </plain></SENT>
<SENT sid="2" pm="."><plain>Eighteen of 22 patients entering the study completed the trial </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with <z:chebi fb="4" ids="2453">acyclovir</z:chebi> failed to alleviate the frequency and severity of orogenital ulceration or other disease features </plain></SENT>
</text></document>